Duchenne Muscular Dystrophy: Exon Skipping and PMO technology
Description: Ms. O’Rourke reviews molecular basis of Duchenne Muscular Dystrophy (DMD), describes exon skipping and Phosphorodiamidate Morpholino Oligomer (PMO) technology, and discusses DMD diagnostic testing: challenges and resources.
At the conclusion of this program, participants will be able to:
- Review molecular basis of Duchenne Muscular Dystrophy (DMD)
- Describe exon skipping and phosphorodiamidate morpholino oligomer (PMO) technology
- Discuss DMD diagnostic testing: challenges and resources
ASCLS P.A.C.E.® credits are available to laboratory professionals through June 5, 2018.